Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)
Rani Therapeutics Holdings (RANI) posted quarterly Return on Invested Capital of 0.18% for Q4 2023, up 203.0% year-over-year from 0.06% in Q4 2022, and up 83.58% quarter-over-quarter from 1.1% in Q3 2023.
Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023) Analysis & Trends
Rani Therapeutics Holdings' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.18% for Q4 2023.
- In Q4 2023, Return on Invested Capital rose 203.0% year-over-year to 0.18%; the TTM figure through Dec 2023 stood at 0.18% (up 203.0% YoY), while the FY2021 annual figure was 3.81%, changed N/A from the prior year.
- Return on Invested Capital for Q4 2023 stood at 0.18%, up from 1.1% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.09% in Q2 2021, with the low at 9.81% in Q2 2023.
- The 3-year median for Return on Invested Capital is 0.23% (2022), against an average of 1.53%.
- Peak annual rise in Return on Invested Capital reached 203 bps in 2023, while the deepest fall reached 953 bps in 2023.
- Rani Therapeutics Holdings' Return on Invested Capital stood at 0.12% in 2021, then tumbled by 1742 bps to 2.21% in 2022, then jumped by 92 bps to 0.18% in 2023.
- Business Quant data shows RANI's Return on Invested Capital at 0.18% in Q4 2023, 1.1% in Q3 2023, and 9.81% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | -1.10% |
| Jun 30, 2023 | -9.81% |
| Dec 31, 2022 | -2.21% |
| Sep 30, 2022 | -1.27% |
| Jun 30, 2022 | -0.28% |
| Mar 31, 2022 | -0.14% |
| Dec 31, 2021 | -0.12% |
| Sep 30, 2021 | -0.10% |
| Jun 30, 2021 | -0.09% |